September 29, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: | Ms. Tracie Mariner |
Mr. Al Pavot
Ms. Julia Griffith
Mr. Dietrich King
Re: | Immunome, Inc. |
Registration Statement on Form S-1
Registration No. 333-248687
Acceleration Request
Requested Date: October 1, 2020
Requested Time: 4:00 PM, Eastern Daylight Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), Ladenburg Thalmann & Co. Inc. and Chardan Capital Markets, LLC, as representatives of the several underwriters, hereby join Immunome, Inc. in requesting that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-248687) (the “Registration Statement”) to become effective on October 1, 2020, at 4:00 PM, Eastern Daylight Time, or as soon as practicable thereafter.
Pursuant to Rule 460 under the Act, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus, to underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement.
We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, to the extent applicable.
[Signature Page Follows]
Very truly yours, | ||
Ladenburg Thalmann & Co. Inc. | ||
By: | /s/ Vlad Ivanov | |
Name: | Vlad Ivanov | |
Title: | Managing Director | |
Chardan Capital Markets, LLC | ||
By: | /s/ Jonas Grossman | |
Name: | Jonas Grossman | |
Title: | President |
cc: | Purnanand Sarma, Ph.D., Immunome, Inc. |
Jeffrey P. Libson, Cooley LLP | |
Ryan S. Sansom, Cooley LLP | |
Geoffrey R. Starr, Cooley LLP | |
Michael D. Maline, Goodwin Procter LLP | |
Michael J. Rosenberg, Goodwin Procter LLP |
[Signature Page to Acceleration Request]